No abstract available
MeSH terms
-
Anti-Bacterial Agents / administration & dosage*
-
Antibiotic Prophylaxis
-
Antiretroviral Therapy, Highly Active
-
Antiviral Agents / administration & dosage
-
CD4-Positive T-Lymphocytes
-
Cytomegalovirus Infections / complications
-
Cytomegalovirus Infections / diagnosis
-
Cytomegalovirus Infections / drug therapy
-
Cytomegalovirus Infections / economics
-
Cytomegalovirus Infections / prevention & control
-
Diagnosis, Differential
-
HIV Infections / complications*
-
HIV Infections / diagnosis
-
HIV Infections / drug therapy
-
HIV Infections / immunology
-
Humans
-
Mycobacterium avium-intracellulare Infection / complications*
-
Mycobacterium avium-intracellulare Infection / diagnosis
-
Mycobacterium avium-intracellulare Infection / drug therapy*
-
Mycobacterium avium-intracellulare Infection / prevention & control
-
Opportunistic Infections / complications*
-
Opportunistic Infections / diagnosis
-
Opportunistic Infections / drug therapy*
-
Opportunistic Infections / prevention & control
-
Pneumonia, Pneumocystis / complications*
-
Pneumonia, Pneumocystis / diagnosis
-
Pneumonia, Pneumocystis / drug therapy*
-
Pneumonia, Pneumocystis / prevention & control
-
Tuberculosis / complications*
-
Tuberculosis / diagnosis
-
Tuberculosis / drug therapy*
-
Tuberculosis / prevention & control
-
Virus Diseases / complications*
-
Virus Diseases / drug therapy*
Substances
-
Anti-Bacterial Agents
-
Antiviral Agents